Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Influenza

CTech 24/7

  • From PayPal roots to global exit: Inside Melio’s $3B sale to Xero
  • Digital farming company Fieldin appoints Iftach Birger as CEO
  • Digital farming company Fieldin appoints Iftach Birger as CEO
  • With AI in hiring, “it’s become harder to distinguish genuine depth,” says MineOS HR
More stories in CTech

Influenza

1 stories about Influenza
  • BiondVax's Ron Babecoff (left) and Tamar Ben-Yedidia. Photo: BiondVax

    Flu Season Might Soon Pass, for Good

    11.12.19|Lilach BaumerThe researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive